Literature DB >> 21030468

Using propensity score modeling to minimize the influence of confounding risks related to prenatal tobacco exposure.

Hua Fang1, Craig Johnson, Nicolas Chevalier, Christian Stopp, Sandra Wiebe, Lauren S Wakschlag, Kimberly Andrews Espy.   

Abstract

INTRODUCTION: Despite efforts to control for confounding variables using stringent sampling plans, selection bias typically exists in observational studies, resulting in unbalanced comparison groups. Ignoring selection bias can result in unreliable or misleading estimates of the causal effect.
METHODS: Generalized boosted models were used to estimate propensity scores from 42 confounding variables for a sample of 361 neonates. Using emergent neonatal attention and orientation skills as an example developmental outcome, we examined the impact of tobacco exposure with and without accounting for selection bias. Weight at birth, an outcome related to tobacco exposure, also was used to examine the functionality of the propensity score approach.
RESULTS: Without inclusion of propensity scores, tobacco-exposed neonates did not differ from their nonexposed peers in attention skills over the first month or in weight at birth. When the propensity score was included as a covariate, exposed infants had marginally lower attention and a slower linear change rate at 4 weeks, with greater quadratic deceleration over the first month. Similarly, exposure-related differences in birth weight emerged when propensity scores were included as a covariate.
CONCLUSIONS: The propensity score method captured the selection bias intrinsic to this observational study of prenatal tobacco exposure. Selection bias obscured the deleterious impact of tobacco exposure on the development of neonatal attention. The illustrated analytic strategy offers an example to better characterize the impact of prenatal tobacco exposure on important developmental outcomes by directly modeling and statistically accounting for the selection bias from the sampling process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030468      PMCID: PMC2991623          DOI: 10.1093/ntr/ntq170

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  24 in total

1.  Propensity score methods in drug safety studies: practice, strengths and limitations.

Authors:  J Wang; P T Donnan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Jun-Jul       Impact factor: 2.890

2.  Rare outcomes, common treatments: analytic strategies using propensity scores.

Authors:  Leonard E Braitman; Paul R Rosenbaum
Journal:  Ann Intern Med       Date:  2002-10-15       Impact factor: 25.391

3.  Prenatal tobacco exposure: developmental outcomes in the neonatal period.

Authors:  Kimberly Andrews Espy; Hua Fang; Craig Johnson; Christian Stopp; Sandra A Wiebe
Journal:  Dev Psychol       Date:  2011-01

Review 4.  Nicotine addiction and comorbidity with alcohol abuse and mental illness.

Authors:  John A Dani; R Adron Harris
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

5.  Propensity score estimation with boosted regression for evaluating causal effects in observational studies.

Authors:  Daniel F McCaffrey; Greg Ridgeway; Andrew R Morral
Journal:  Psychol Methods       Date:  2004-12

6.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

7.  Smoking and drinking during pregnancy. Their effects on preterm birth.

Authors:  P H Shiono; M A Klebanoff; G G Rhoads
Journal:  JAMA       Date:  1986-01-03       Impact factor: 56.272

Review 8.  Prenatal and postnatal environmental tobacco smoke exposure and children's health.

Authors:  Joseph R DiFranza; C Andrew Aligne; Michael Weitzman
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

9.  Depression, anxiety, and smoking initiation: a prospective study over 3 years.

Authors:  G C Patton; J B Carlin; C Coffey; R Wolfe; M Hibbert; G Bowes
Journal:  Am J Public Health       Date:  1998-10       Impact factor: 9.308

10.  Psychiatric comorbidity of smoking and nicotine dependence.

Authors:  N Breslau
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

View more
  6 in total

1.  Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior.

Authors:  Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis
Journal:  Neurotoxicol Teratol       Date:  2018-09-26       Impact factor: 3.763

2.  Does early maternal responsiveness buffer prenatal tobacco exposure effects on young children's behavioral disinhibition?

Authors:  Caron A C Clark; Suena H Massey; Sandra A Wiebe; Kimberly Andrews Espy; Lauren S Wakschlag
Journal:  Dev Psychopathol       Date:  2019-10

3.  A new look at quantifying tobacco exposure during pregnancy using fuzzy clustering.

Authors:  Hua Fang; Craig Johnson; Christian Stopp; Kimberly Andrews Espy
Journal:  Neurotoxicol Teratol       Date:  2011 Jan-Feb       Impact factor: 3.763

4.  A Propensity Scoring Approach to Characterizing the Effects of Maternal Smoking During Pregnancy on Offspring's Initial Responses to Cigarettes and Alcohol.

Authors:  L Cinnamon Bidwell; Rohan H C Palmer; Leslie Brick; Pamela A F Madden; Andrew C Heath; Valerie S Knopik
Journal:  Behav Genet       Date:  2016-04-20       Impact factor: 2.805

5.  Determining the impact of prenatal tobacco exposure on self-regulation at 6 months.

Authors:  Sandra A Wiebe; Hua Fang; Craig Johnson; Karen E James; Kimberly Andrews Espy
Journal:  Dev Psychol       Date:  2014-02-10

6.  Epidemiology of Functional abdominal bloating and its impact on health related quality of life: male-female stratified propensity score analysis in a population based survey in mainland China.

Authors:  Meijing Wu; Yanfang Zhao; Rui Wang; Wenxin Zheng; Xiaojing Guo; Shunquan Wu; Xiuqiang Ma; Jia He
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.